Agenda

Registration and refreshments

07:30

Registration and refreshments

Breakfast Session 1: Clinical trial endpoints

Chairs: Dr Mark E. Jones, Dr John Rex

08:00

Adjustment of clinical trial endpoints for invasive, chronic pulmonary aspergillosis and mucormycosis

Professor Monica Slavin, Professor Martin Hoenigl, Professor Ritesh Agarwal

Welcome and introductory remarks

09:00

Welcome to Rennes

Professor Jean-Pierre Gangneux

0905

Summary of global disease burden

Professor David W. Denning

Session 1: SWOT analyses for new diagnostics

Chairs: Associate Professor Sarah Kidd, Professor Rita Oladele

09:15

TBC

09:35

Urinary siderophore detection

Professor Vladimír Havlíček

09:55

Abstract 1

10:05

Abstract 2

10:15

Abstract 3

10:25

Use and interpretation of Aspergillus IgG antibody for diagnosing IPA in non-immunocompromised patients, CPA and other entities

Professor Koichi Izumikama

10:45

Discussion

Refreshment Break

10:55

Refreshment break, Networking and Poster viewing

Session 2: Resistance in Aspergillus – an ongoing saga

Chairs: Associate Professor Eveline Snelders, Professor Michael Bromley

11:25

Azole resistance in Aspergillus niger complex

Lance Price

11:45

Abstract 1

11:55

Abstract 2

12:05

Antifungal resistance in Aspergillus flavus

Professor Amelia Barber

12:25

Discussion

Lunch Break

12:45

Lunch break, Networking and Poster viewing

Session 3: New paradigms for understanding and managing respiratory Aspergillus and Mucorales infections

Chairs: Dr Marisa Miceli, Professor Jean-Pierre Gangneux

14:00

The changing epidemiology of aspergillosis in CF patients

Professor Eva Van Braeckel

14:20

Immunological control of pulmonary mucormycosis – a novel mechanism

Dr Georgios Chamilos

14:40

The SFMM lecture. Who should be tested for Mucorales by PCR, when and how often?

Professor Laurence Millon

15:00

Abstract

15:20

Diagnostic criteria and pre-emptive approach to invasive pulmonary aspergillosis in COPD

Dr Takahiro Takazono

15:40

Discussion

Refreshment Break

15:55

Refreshment break, Networking and Poster viewing

Session 4: Challenging clinical scenarios for clinicians

Chairs: Professor Claire Andrejak, Professor Koichi Izumikama

16:20

The SPLF lecture. When to consider aspergillosis in patients with NTM and pulmonary TB infections

Professor Claire Andrejak

16:40

Improving outcomes of severe asthma with fungal sensitisation – next steps?

Camille Taillé

16:50

Abstract

17:00

To what extent does Aspergillus drive COPD exacerbations?

Dr Pei Yee Tiew

17:20

What is the role of reducing environmental control in improving disease control in chronic fungal lung disease?

Professor Jean-Pierre Gangneux

17:40

The promise of the next generation of oral and inhaled antifungal agents for aspergillosis and mucormycosis

Dr Marisa Miceli

18:00

Discussion

Welcome reception

18:45

Session 5: Product Update

Chair: Professor Oliver Cornely

08:00

Presentation 1

08:10

Presentation 2

08:20

Presentation 3 - Basilea

Dr Mark E. Jones

08:30

Presentation 4 - BioMerieux

08:40

Presentation 5 - BioRad

08:50

Presentation 6

Session 6: Defence and virulence

Chairs: Dr Robert A. Cramer, Dr Michelle Momany

09:10

NK cell defence against Aspergillus spp.

Professor Bruce Klein

09:35

How do mycoviruses confer additional virulence in Aspergillus fumigatus?

Dr Marina Campos Rocha

09:55

Abstract 1

10:05

Abstract 2

10:15

What part do interferons play in defence against invasive and chronic pulmonary aspergillosis?

Dr Kelly Shepardson

10:35

Discussion

Refreshment Break

10:50

Refreshment break, Networking and Poster viewing

Session 7: Chronic fungal lung disease and exposure

Chairs: Professor Yinggai Song, Professor Eva Van Braeckel

11:20

What is wrong with epithelial cells when aspergillosis occurs?

Dr Margherita Bertuzzi

11:40

ABPA in COPD patients

Professor Yongchang Sun

12:00

Abstract 1

12:10

Abstract 2

12:20

Respirable mycotoxins and flooding – how should we approach it?

Professor Maja Šegvić Klarić

12:40

Discussion

Lunch Break

13:00

Lunch break, Networking and Poster viewing

Meet the expert collaboration

Breakfast Session 2: Policy debate re: resistance

08:00

Fungicides with common modes of action to clinical antifungals that confer resistance in Aspergillus should not be registrable for environmental use

Dr Michael Bottery

08:15

Concerns about antifungal resistance must account for the vital role of fungicides in global food security

Dr Kevin Doughty

08:30

Discussion

Session 8: Risk factors for aspergillosis and mucormycosis

Chairs: Dr Sarah Dellière, Professor Ritesh Agarwal

09:00

How big a problem is fungal sinusitis?

Dr Sarah Ahmed

09:20

Who is most at risk of dying of invasive aspergillosis?

Dr Yuya Kimura

09:40

Who is most at risk of dying of invasive mucormycosis?

Professor Fanny Lanternier

10:00

IA and interstitial lung disease – who is at risk and why?

Professor Xin Su

10:20

Group discussion

Refreshment Break

10:30

Refreshment break, Networking and Poster viewing

Session 9: Aspergillus Guidelines

Chairs: Professor Oliver Cornely, Professor David W. Denning

11:00

The global aspergillosis guidelines – Diagnostics

Professor Corneila Lass-Florl

11:20

ICU IA diagnostic approach

Dr Simon Feys

11:40

IA treatment guideline summary

Dr Jannik Stemler

12:00

Fungal asthma/ABPA management

Professor Ritesh Agarwal

12:20

Discussion

Conference End

12:30

Closing remarks

Professor Jean-Pierre Gangneux